DDX3X and extranodal nasal NK/T cell lymphoma: The recurrent mutation of DDX3X was also detected in Natural killer/T-cell lymphoma (NKTCL) patients and resulted in the aberrant cell cycle progression and NF-κB/MAPK signaling activation [29].